EXPAREL (TM) approved by US FDA for postsurgical pain management

被引：0

|

作者：

Gunawardana, Roshaine

机构：

来源：

PAIN MANAGEMENT | 2012年 / 2卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

收藏

页码：15 / 15

页数：1

相关论文

共 50 条

[41] Management of persistent postsurgical inguinal pain
Werner, Mads U.
LANGENBECKS ARCHIVES OF SURGERY, 2014, 399 (05) : 559 - 569
[42] Bedaquiline approved by the US FDA for multidrug-resistant tuberculosis
Attwood, Claire
EXPERT REVIEW OF RESPIRATORY MEDICINE, 2013, 7 (01) : 11 - 11
[43] US FDA approves Tribenzor (TM) for the treatment of hypertension
不详
EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2010, 8 (09) : 1212 - 1212
[44] Vismodegib approved by US FDA for the treatment of advanced basal cell carcinoma
Attwood, Claire
FUTURE ONCOLOGY, 2012, 8 (03) : 227 - 227
[45] Votrient™ approved by the US FDA for advanced soft-tissue sarcoma
O'Hare, Alice
IMMUNOTHERAPY, 2012, 4 (06) : 572 - 572
[46] Procedure-specific Pain Management The Road to Improve Postsurgical Pain Management?
Joshi, Girish P.
Kehlet, Henrik
ANESTHESIOLOGY, 2013, 118 (04) : 780 - 782
[47] Highlights on Fluorine-Containing Drugs Approved by US FDA in 2023
Ali, Saghir
Bolinger, Andrew A.
Zhou, Jia
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2024, 24 (10) : 843 - 849
[48] Once-daily rilpivirine approved by the US FDA for HIV infection
不详
FUTURE VIROLOGY, 2011, 6 (07) : 791 - 791
[49] Analysis of US FDA-Approved Drugs Containing Sulfur Atoms
Kevin A. Scott
Jon T. Njardarson
Topics in Current Chemistry, 2018, 376
[50] First new therapy for lupus approved by the US FDA since 1955
不详
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2011, 7 (03) : 263 - 263

← 1 2 3 4 5 →